17-43134805-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001408458.1(BRCA1):​c.-61-19026A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.319 in 151,852 control chromosomes in the GnomAD database, including 8,032 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8032 hom., cov: 31)

Consequence

BRCA1
NM_001408458.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.40

Publications

16 publications found
Variant links:
Genes affected
NBR2 (HGNC:20691): (neighbor of BRCA1 lncRNA 2) This gene was identified by its close proximity on chromosome 17 to tumor suppressor gene BRCA1. Experimental evidence indicates that the two genes share a bi-directional promoter. Transcription for either gene is controlled individually by distinct transcriptional repressor factors. A short (112 amino acid) open reading frame is observed which includes a region derived from a LINE1 element. A strong Kozak signal is not observed for the putative ORF and the stop codon is more than 55 nucleotides upstream of the last splice site for the transcript, suggesting that the transcript is subject to nonsense-mediated decay. Therefore, this gene does not appear to encode a protein. Glucose starvation induces the expression of this gene and the long non-coding RNA transcribed by it functions with AMP-activated protein kinase in mediating the energy stress response. [provided by RefSeq, Aug 2016]
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.478 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001408458.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_001408458.1
c.-61-19026A>C
intron
N/ANP_001395387.1B4DES0
NBR2
NR_003108.2
n.277+3535T>G
intron
N/A
NBR2
NR_138145.1
n.584+1668T>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBR2
ENST00000356906.8
TSL:1
n.414+3535T>G
intron
N/A
BRCA1
ENST00000634433.2
TSL:5
c.-19-10690A>C
intron
N/AENSP00000489431.2A0A0U1RRA9
NBR2
ENST00000460115.5
TSL:2
n.224+3535T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.319
AC:
48336
AN:
151734
Hom.:
8026
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.236
Gnomad AMI
AF:
0.286
Gnomad AMR
AF:
0.333
Gnomad ASJ
AF:
0.363
Gnomad EAS
AF:
0.371
Gnomad SAS
AF:
0.495
Gnomad FIN
AF:
0.404
Gnomad MID
AF:
0.360
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.336
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.319
AC:
48375
AN:
151852
Hom.:
8032
Cov.:
31
AF XY:
0.325
AC XY:
24102
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.236
AC:
9761
AN:
41410
American (AMR)
AF:
0.334
AC:
5092
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
1260
AN:
3470
East Asian (EAS)
AF:
0.371
AC:
1913
AN:
5160
South Asian (SAS)
AF:
0.495
AC:
2382
AN:
4814
European-Finnish (FIN)
AF:
0.404
AC:
4253
AN:
10522
Middle Eastern (MID)
AF:
0.360
AC:
105
AN:
292
European-Non Finnish (NFE)
AF:
0.333
AC:
22633
AN:
67900
Other (OTH)
AF:
0.340
AC:
716
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1661
3323
4984
6646
8307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
500
1000
1500
2000
2500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.264
Hom.:
1381
Bravo
AF:
0.304
Asia WGS
AF:
0.421
AC:
1462
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
2.1
DANN
Benign
0.31
PhyloP100
-1.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2175957; hg19: chr17-41286822; API